Burlina A B
Department of Pediatrics, University Children's Hospital, Padua, Italy.
J Inherit Metab Dis. 2004;27(3):373-83. doi: 10.1023/B:BOLI.0000031095.57411.8d.
Liver transplantation for inborn errors of metabolism has proved effective in some (mostly liver-associated) inborn errors of metabolism. Significant morbidity and mortality rates have been extensively reported due to disease recurrence or to complications of the immunosuppressive regimen. On the basis of clinical trials in animals as well as in humans, the use of isolated hepatocytes offers a unique opportunity for treating inborn errors of metabolism. The state of art of the technique applied to this field is reviewed here and related practical problems are examined. No final conclusions can be drawn, but further insight into the use of alternative sources of cells, including stem/progenitor cells associated with cryobiology and immunological research, will offer new opportunities for cell therapy for inborn errors of metabolism in the near future.
对于某些(主要是与肝脏相关的)先天性代谢缺陷疾病,肝移植已被证明是有效的。由于疾病复发或免疫抑制方案的并发症,已广泛报道了显著的发病率和死亡率。基于动物和人类的临床试验,使用分离的肝细胞为治疗先天性代谢缺陷提供了独特的机会。本文综述了应用于该领域的技术现状,并探讨了相关的实际问题。虽然无法得出最终结论,但进一步深入研究包括与低温生物学和免疫学研究相关的干细胞/祖细胞在内的替代细胞来源的使用,将在不久的将来为先天性代谢缺陷的细胞治疗提供新的机会。